Trials
Search / Trial NCT06441942

Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

Launched by IRCCS SAN RAFFAELE · May 29, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Not yet recruiting

Keywords

Acs Gedi Genetic Dna M Rna Proteomic Metabolomic

ClinConnect Summary

Create a multicenter prospective registry that collects information from women affected by acute coronary syndrome (ACS) from a wide range of cultural and ethnic backgrounds distributed across various Italian regions. This registry aims to understand the diversity in the presentation of women with ACS in Italy, providing valuable data for a better understanding of the disease.

Additionally, it proposes to conduct a thorough characterization of the women involved in the study through genetic, biochemical, and molecular analysis. This analysis will be stratified by age and the etiology of co...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • • Women \>/= 18 years with ACS (STEMI, NSTEMI or Unstable Angina).
  • Exclusion Criteria:
  • • age \< 18 years and/or unwillingness to sign informed consent and/or unwillingness to make follow-up visits

About Irccs San Raffaele

IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.

Locations

Milano, Italy Milan, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0